FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

'Severely infectious' bacterial strain can survive in contact lens solution Apr 17, 1:30 pm
Washington, April 17 (ANI): Scientists have found a bacterial strain that is associated with more severe infections and survives longer in contact lens disinfectant solution.
Full Story
BMI linked to postmenopausal breast cancer regardless of body shape Apr 17, 11:40 am
Washington, April 17 (ANI): A new study has revealed that Body Mass Index associated with breast cancer, regardless of body shape.
Full Story
TV smoking triggers adult tobacco use Apr 17, 10:59 am
Washington, Apr 17 (ANI): A new study suggests that even though smoking appears far less frequently in US television shows than it used to, its portrayal may still be triggering the urge in adult smokers.
Full Story
Cheap 'magic' polypill helps fight heart diseases Apr 16, 12:01 pm
London, April 16 (ANI): Scientists have revealed that a polypill that is packed with aspirin, a statin and a blood-pressure drug can help fight heart diseases.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY